Overview

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

Status:
Not yet recruiting
Trial end date:
2023-05-06
Target enrollment:
Participant gender:
Summary
A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-391
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical